Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HHT7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.378 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.608 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.382 |
DEG_SCF_FBW7_1 | 164 | 169 | PF00400 | 0.435 |
DOC_CYCLIN_RxL_1 | 5 | 16 | PF00134 | 0.613 |
DOC_CYCLIN_yCln2_LP_2 | 34 | 40 | PF00134 | 0.566 |
DOC_PP1_RVXF_1 | 6 | 13 | PF00149 | 0.636 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.423 |
DOC_WW_Pin1_4 | 162 | 167 | PF00397 | 0.404 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.623 |
LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.635 |
LIG_BRCT_BRCA1_1 | 105 | 109 | PF00533 | 0.274 |
LIG_deltaCOP1_diTrp_1 | 75 | 82 | PF00928 | 0.436 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.476 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.348 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.660 |
LIG_Integrin_RGD_1 | 14 | 16 | PF01839 | 0.324 |
LIG_LIR_Apic_2 | 175 | 179 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 137 | 147 | PF02991 | 0.237 |
LIG_LIR_Gen_1 | 169 | 178 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 137 | 142 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 182 | 188 | PF02991 | 0.372 |
LIG_LRP6_Inhibitor_1 | 87 | 93 | PF00058 | 0.185 |
LIG_MLH1_MIPbox_1 | 105 | 109 | PF16413 | 0.274 |
LIG_MYND_1 | 33 | 37 | PF01753 | 0.523 |
LIG_NRBOX | 6 | 12 | PF00104 | 0.639 |
LIG_PALB2_WD40_1 | 49 | 57 | PF16756 | 0.495 |
LIG_Pex14_1 | 78 | 82 | PF04695 | 0.271 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.393 |
LIG_SH2_CRK | 188 | 192 | PF00017 | 0.406 |
LIG_SH2_CRK | 31 | 35 | PF00017 | 0.602 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.289 |
LIG_SH2_GRB2like | 88 | 91 | PF00017 | 0.289 |
LIG_SH2_PTP2 | 176 | 179 | PF00017 | 0.372 |
LIG_SH2_SRC | 145 | 148 | PF00017 | 0.336 |
LIG_SH2_SRC | 176 | 179 | PF00017 | 0.372 |
LIG_SH2_STAP1 | 181 | 185 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.413 |
LIG_SH3_3 | 184 | 190 | PF00018 | 0.377 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.650 |
LIG_TYR_ITIM | 186 | 191 | PF00017 | 0.395 |
LIG_TYR_ITIM | 87 | 92 | PF00017 | 0.404 |
LIG_WRC_WIRS_1 | 60 | 65 | PF05994 | 0.636 |
LIG_WW_1 | 178 | 181 | PF00397 | 0.315 |
MOD_CDK_SPxK_1 | 162 | 168 | PF00069 | 0.439 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.631 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.446 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.252 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.441 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.369 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.185 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.420 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.636 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.599 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.556 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.562 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.185 |
MOD_NEK2_2 | 134 | 139 | PF00069 | 0.185 |
MOD_NEK2_2 | 88 | 93 | PF00069 | 0.376 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.233 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.566 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.451 |
MOD_ProDKin_1 | 162 | 168 | PF00069 | 0.407 |
TRG_DiLeu_BaLyEn_6 | 30 | 35 | PF01217 | 0.600 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 188 | 191 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.580 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.289 |
TRG_ER_diArg_1 | 160 | 162 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 71 | 74 | PF00400 | 0.534 |
TRG_ER_FFAT_2 | 61 | 68 | PF00635 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 8 | 13 | PF00026 | 0.417 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZV8 | Leptomonas seymouri | 74% | 100% |
A0A0S4KHT2 | Bodo saltans | 40% | 94% |
A0A1X0P8Y9 | Trypanosomatidae | 60% | 99% |
A0A3Q8IHI8 | Leishmania donovani | 84% | 100% |
A4I4Y8 | Leishmania infantum | 84% | 100% |
C9ZKK1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 98% |
E9AEE1 | Leishmania major | 84% | 100% |
E9ALE5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
V5BXI8 | Trypanosoma cruzi | 58% | 99% |